Free Trial

Cyclacel Pharmaceuticals (CYCC) News Today

Cyclacel Pharmaceuticals logo
$0.50
-0.12 (-19.20%)
(As of 11/4/2024 ET)
What is Roth Capital's Forecast for CYCC FY2027 Earnings?
Cyclacel Pharmaceuticals granted extension for regain Nasdaq compliance
Cyclacel Pharmaceuticals Inc
Cyclacel Pharmaceuticals, Inc. (CYCCP)
Cyclacel Pharmaceuticals Inc. (UXI.SG)
Cyclacel Pharmaceuticals Announces Reverse Stock Split
Cyclacel Pharmaceuticals Inc CYCC
Get Cyclacel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYCC and its competitors with MarketBeat's FREE daily newsletter.

Ticking time bomb. Detonation Nov 5 (Ad)

Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late.

Watch this video, it is being taken down Monday night

CYCC Media Mentions By Week

CYCC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYCC
News Sentiment

-0.50

0.46

Average
Medical
News Sentiment

CYCC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYCC Articles
This Week

4

1

CYCC Articles
Average Week

Get Cyclacel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYCC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CYCC) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners